ArticleTransport policy2021
Impacts of COVID-19 and anti-pandemic policies on urban transport-an empirical study in China.
Article in Transport policy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Impact of battery electric vehicle usage on air quality in three Chinese first-tier cities.Scientific reports · 2024Article
- Article
- Analyzing multiple COVID-19 outbreak impacts: A case study based on Chinese national air passenger flow.Transportation research. Part A, Policy and practice · 2023Article
- Road crash risk prediction during COVID-19 for flash crowd traffic prevention: The case of Los Angeles.Computer communications · 2023Article
- On the bumpy road to recovery: resilience of public transport ridership during COVID-19 in 15 European cities.Letters in spatial and resource sciences · 2023Article
- Spatial co-location patterns between early COVID-19 risk and urban facilities: a case study of Wuhan, China.Frontiers in public health · 2023Article
- Challenges for urban transport policy after the Covid-19 pandemic: Main findings from a survey in 20 European cities.Transport policy · 2022Article
- Data analytics during pandemics: a transportation and location planning perspective.Annals of operations research · 2022Article
- Research frontier of COVID-19 and passenger transport: A focus on policymaking.Transport policy · 2022Article
- Study on the influence of COVID-19 on the growth of China's small and medium-sized construction enterprises.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic that began in the last quarter of 2019 seriously impacted the transportation industry. Countries around the world adopted various restrictions and policies to prevent the spread of the pandemic, which resulted in a sharp drop in the demand for transportation. China was the first country to detect the pandemic and the fastest to recover. Existing policies and impacts were reviewed to analyze the impact of the pandemic on China's urban transportation sector and propose measures that may be taken to reduce the impact of COVID-19. This study reviews the impact on urban transportation system operations and how government should respond to a viral pandemic. The recovery measures during and after the pandemic and their hierarchical response system are analyzed. Furthermore, to empirically explore the effect of the recovery measures, this study adopted the Event Study Methodology (ESM) to quantitatively analyze the impact of the epidemic as well as anti-pandemic policies on the traffic flow sequence in the resurgence of COVID-19 in Beijing. The research findings provided solid policy implications and experiences for constructing sustainable urban transportation system and improve flexibility, reliability, and resilience of traffic governance in post-pandemic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.